Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: A randomized pilot study

Nutrition

Volumn 21, Issue 2, 2005, Pages 170-178

  Persson, Christina ^a,b   Glimelius, Bengt ^a   Rönnelid, Johan ^a   Nygren, Peter ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cachexia; Fish oil; Gastrointestinal cancer; Melatonin

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; LINOLEIC ACID; MELATONIN; SERUM ALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CACHEXIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; FEMALE; GASTROINTESTINAL CARCINOMA; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION;

EID: 13844299005     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2004.05.026     Document Type: Article

References (27)

1. E. Bruera, and C. Sweeney Cachexia and asthenia in cancer patients Lancet 1 2000 138 147
2. T. Preston, C. Slater, D.C. McMillan, J.S. Falconer, and A. Shenkin Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response J Nutr 128 1998 1355 1360
3. S.J. Wigmore, P.T. Todrov, and M.D. Barber Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor Br J Surg 87 2000 53 58
4. J.M. Argiles, and F.J. Lopez-Soriano Catabolic proinflammatory cytokines Curr Opin Clin Nutr Metab Care 1 1998 245 251
5. M.D. Barber Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation Nutrition 17 2001 751 755
6. A. Laviano, and M.M. Meguid Nutritional issues in cancer management Nutrition 12 1996 358 371
7. M. Shibata, and M. Takekawa Increased serum concentration of circulating soluble receptor for interleukin-2 and its effect as a prognostic indicator in cachectic patients with gastric and colorectal cancer Oncology 56 1999 54 58
8. S.J. Wigmore, K.C.H. Fearon, J.P. Maingay, P.B.S. Lai, and J.A. Ross Interleukine-8 can mediate acute-phase protein production by isolated human hepatocytes Am J Physiol 273 1997 E720 E726
9. M.J. Tisdale Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia Nutrition 12 suppl 1 1996 S31 S33
10. M.D. Barber, J.A. Ross, M.J. Tisdale, and K.C.H. Fearon The effect of an oral nutritional supplement enriched with fish-oil on weight-loss in patients with pancreatic cancer Br J Cancer 81 1999 80 86
11. M.D. Barber, J.A. Ross, T. Preston, A. Shenkin, and K.C.H. Fearon Fish-oil-enriched nutritional supplements attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer J Nutr 129 1999 1120 1125
12. A. Brzezinski Melatonin in humans N Engl J Med 336 1997 186 195
13. P. Lissoni, F. Paolorossi, and G. Tancini Is there a role for melatonin in the treatment of neoplastic cachexia? Eur J Cancer 32A 1996 1340 1343
14. D.E. Blask, L.A. Sauer, and R.T. Dauchy Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acids metabolism via melatonin receptor-mediated signal transduction events Cancer Res 59 1999 4693 4701
15. P.S. Lissoni, M. Manila, and A. Ardizzoia Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumor patients with poor clinical status Eur J Cancer 35 1999 1688 1692
16. N.K. Aaronson, S. Ahmedzai, and B. Bergman The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
17. Nordic Council of Ministers Nordic nutrition recommendations 1996 Scand J Nutr 4 1996 161 165
18. O. Haglund, R. Wallin, R. Luostarinen, and T. Saldeen Effects of a new fluid fish oil concentrate, Eskimo-3, on triglycerides, cholesterol, fibrinogen and blood pressure J Intern Med 227 1990 347 353
19. S.J. Wigmore, K.C.H. Fearon, J.P. Maingay, and J.A. Ross Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6 Clin Sci 92 1997 215 221
20. S.J. Wigmore, J.A. Ross, and J.S. Falconer The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer Nutrition 12 suppl 1996 S27 S30
21. N. Petrovsky, P. McNair, and L.C. Harrison Diurnal rhythms of pro-inflammatory cytokines: regulation y plasma cortisol and therapeutic implications Cytokine 10 1998 307 312
22. M.D. Barber, T. Preston, J.A. Ross, and K.C.H. Fearon Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement Clin Sci 98 2000 389 399
23. C.A. Gogos, P. Ginopoulos, B. Salsa, and E. Apostolidou Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized trial Cancer 82 1998 395 402
24. C.P. Burns, S. Halabi, and G. Clamon Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: Cancer and Leukaemia Group B Study 9473 Clin Cancer Res 5 1999 3942 3947
25. L.A. Sauer, R.T. Dauchy, and D.E. Blask Polyunsaturated fatty acids, melatonin and cancer prevention Biochem Pharmacol 61 2001 1455 1462
26. W.E. Hardman, C.P. Avuola, G. Fernandes, and I.L. Cameron Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-231 breast cancer xenografts Clin Cancer Res 7 2001 2041 2049
27. P. Lissoni, F. Rovelli, and F. Malugani Anti-angiogenic activity of melatonin in advanced cancer patients Neuroendocrinol Lett 22 2001 45 47